APRIL SIMKINS: Open Payments
NPI 1538266697 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 34 payments from 7 companies in 2025. Trend: 2023 $732 · 2024 $608 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 18 | $212 |
| ABBVIE INC. | 5 | $107 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $106 |
| PFIZER INC. | 2 | $44 |
| Azurity Pharmaceuticals, Inc. | 2 | $44 |
| Averitas Pharma Inc. | 1 | $32 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
Products named: Belbuca, RELISTOR, QULIPTA, HORIZANT, UBRELVY, QUTENZA, XTAMPZA, ZAVZPRET.
Industry payments across UT — which companies pay providers there.
